FDA Regulation Cluster Is Already in Tier-1, But the Trade Is Now About Timing, Not Discovery
The Opportunity
This is a broad FDA-regulation cluster with a negative mechanism (compliance tightening / regulatory pressure) that the pipeline has already flagged as spreading with Tier-1 participation. That is why it sits in propagation_monitor: the market knows the topic, and any remaining edge is about sequencing, scope, and which sub-sectors get hit first. The directional call stays SHORT, but the product here is an index expression (IHE/XBI) rather than an issuer-specific bombshell.
The Timing
The environment is Mixed 62 with high crosswind risk (72), which is exactly when broad regulatory shorts can whipsaw. The conversion from INVESTIGATE to TRADE needs one missing piece: a single, concrete FDA artefact (guidance, warning, enforcement action) that cleanly anchors the cluster and narrows the exposure set. Without that, you are trading noise around a widely visible theme.
The Evidence
Upstream routing explicitly marks Tier-1 coverage present and edge decaying, and hydration is missing in this payload, so we cannot cite a clean list of primary URLs here. Treat this as a timing/interpretation problem, not a discovery problem: if you want to press it, you need the specific FDA document and a map from that document to the most exposed product lines and issuers.